Fidelity Investments’s PROSENSA HLDGS N V ORD SHS (NLD) RNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-863,241
Closed -$7.28M 2901
2014
Q3
$7.28M Buy
863,241
+507,429
+143% +$4.81M ﹤0.01% 2110
2014
Q2
$4.49M Sell
355,812
-20,500
-5% -$166K ﹤0.01% 2263
2014
Q1
$2.12M Buy
+376,312
New +$2.33M ﹤0.01% 2375

Other funds holding RNA

Fidelity Investments's RNA Position: Q4 2014 in Review

Fidelity Investments sold out of PROSENSA HLDGS N V ORD SHS (NLD) (RNA) in Q4 2014, closing a stake of 863,241 shares — an estimated $7.28M sold.

Fidelity Investments first reported a position in RNA in Q1 2014 and held it in 3 quarters. The position peaked at $7.28M in Q3 2014. 47 funds tracked by Wall St. Rank hold RNA as of Q4 2014.

  • Fidelity Investments reported no remaining PROSENSA HLDGS N V ORD SHS (NLD) position as of Q4 2014 after selling out during the quarter.
  • Fidelity Investments sold 863,241 PROSENSA HLDGS N V ORD SHS (NLD) shares in Q4 2014, an estimated $7.28M.
  • Fidelity Investments first reported a position in PROSENSA HLDGS N V ORD SHS (NLD) in Q1 2014 and held it in 3 quarters.
  • Fidelity Investments's PROSENSA HLDGS N V ORD SHS (NLD) position peaked at $7.28M in Q3 2014.
  • 47 funds tracked by Wall St. Rank held PROSENSA HLDGS N V ORD SHS (NLD) as of Q4 2014.

Based on Fidelity Investments's 13F filing for Q4 2014, filed 17 Feb 2015.